Souhaitez-vous accéder aux communiqués récents ?

MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries Prospective clinical data show NexoBrid® removes...

Boston, Dec. 09, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Separation Systems for Commercial Biotechnology” is projected to grow from $32.5 billion in 2025 to $45.1...

– 98% reduction in HSV-2 shedding rate, >99% reduction in high viral load shedding rate and 91% reduction in virologically confirmed genital lesion rate observed in 50 mg weekly oral dose of...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Nanopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Medication Adherence Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Bags Aseptic Filling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The 2025 iC³® Life Science & Healthcare Innovation Summit, hosted by BioNTX, concluded on September 16–17 at the Hilton Anatole in Dallas, marking more...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Iron Deficiency Anemia Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ...

MannKind Announces U.S. FDA Accepts for Review its sNDA of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in adults with CHF or CKD